Advertisement

Psychopharmacology

, Volume 222, Issue 1, pp 173–183 | Cite as

Probabilistic classification and gambling in patients with schizophrenia receiving medication: comparison of risperidone, olanzapine, clozapine and typical antipsychotics

  • James I. Wasserman
  • Rebecca J. Barry
  • Lisa Bradford
  • Nicholas J. Delva
  • Richard J. Beninger
Original Investigation

Abstract

Rationale

We have previously shown that patients with schizophrenia treated with typical antipsychotics were impaired on the weather prediction probabilistic classification learning (PCL) task that relies on striatal function, and that similar patients treated with atypical antipsychotics were impaired on the Iowa gambling task (IGT) that depends on medial prefrontocortical function.

Objectives

We tested the hypothesis that test performance of patients treated with risperidone will be more similar to those treated with typical rather than atypical antipsychotics.

Results

Groups of schizophrenia patients treated with risperidone, olanzapine, clozapine or typical antipsychotics did not differ on the Positive and Negative Syndrome Scale or the Mini Mental State Exam (MMSE) but scored lower than controls on the MMSE. For the PCL task, patients treated with clozapine improved over trials while those treated with typical antipsychotics, olanzapine, or risperidone did not. For the IGT, patients treated with typical antipsychotics or risperidone improved over trials while those treated with clozapine or olanzapine did not.

Conclusions

Results generally supported the hypothesis that patients treated with risperidone perform more like those treated with typical antipsychotics than those treated with other atypical antipsychotics.

Keywords

Declarative memory Dopamine Striatum 

Notes

Acknowledgments

This study was funded by Queen’s University.

References

  1. Allain H, Lieury A, Thomas V, Reymann JM, Gandon JM, Belliard S (1995) Explicit and procedural memory in Parkinson’s disease. Biomed Pharmacother 49:179–186PubMedCrossRefGoogle Scholar
  2. Aron AR, Shohamy D, Clark J, Myers C, Gluck MA, Poldrack RA (2004) Human midbrain sensitivity to cognitive feedback and uncertainty during classification learning. J Neurophysiol 92:1144–1152PubMedCrossRefGoogle Scholar
  3. Bechara A (2004) The role of emotion in decision making: evidence from neurological patients with orbitofrontal damage. Brain Cognit 55:30–40CrossRefGoogle Scholar
  4. Bechara A, Damasio H, Tranel D (1997) Deciding advantageously before knowing the advantageous strategy. Science (Wash) 275:1293–1295CrossRefGoogle Scholar
  5. Bechara A, Damasio H, Damasio A, Lee G (1999) Different contributions of the human amygdala and ventromedial prefrontal cortex to decision making. J Neurosci 19:5473–5481PubMedGoogle Scholar
  6. Bechara A, Tranel D, Damasio H (2000) Characterization of the decision-making deficit of patients with ventromedial prefrontal cortex lesions. J Neurol 123:2189–2202Google Scholar
  7. Bedard MA, Scherer H, Stip E, Cohen H, Rodriguez JP, Richer F (2000) Procedural learning in schizophrenia: further consideration on the deleterious effect of neuroleptics. Brain Cogn 43:31–39Google Scholar
  8. Beninger RJ, Wasserman J, Zanibbi K, Charbonneau D, Mangels J, Beninger B (2003) Typical and atypical antipsychotic medications differentially affect two nondeclarative memory tasks in schizophrenic patients: a double dissociation. Schizophr Res 61:281–292PubMedCrossRefGoogle Scholar
  9. Beninger RJ, Baker TW, Florczynski MM, Banasikowski TJ (2010) Regional differences in the action of antipsychotic drugs: implications for cognitive effects in schizophrenic patients. Neurotox Res 18:229–243PubMedCrossRefGoogle Scholar
  10. Bilder RM, Goldman RS, Robinson D, Reiter G, Bell L, Bates JA et al (2000) Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates. Am J Psychiatr 157:549–559PubMedCrossRefGoogle Scholar
  11. Brand M, Kalbe E, Labudda K, Fujiwara E, Kessler J, Markowitsch HJ (2005) Decision-making impairments in patients with pathological gambling. Psychiatr Res 133:91–99CrossRefGoogle Scholar
  12. Charbonneau D, Riopelle RJ, Beninger RJ (1996) Impaired incentive learning in treated Parkinson’s disease. Can J Neurol Sci 23:271–278PubMedGoogle Scholar
  13. Ernst M, Bolla K, Mouratidis M, Contoreggi C, Matochik JA, Kurian V, Cadet JL, Kimes AS, London ED (2002) Decision making in a risk-taking task: a PET study. Neuropsychopharmacol 26:682–691CrossRefGoogle Scholar
  14. Fischman MW, Schuster CR (1979) The effects of chlorpromazine and pentobarbital on behavior maintained by electric shock or point loss avoidance in humans. Psychopharmacology (Berlin) 66:3–11CrossRefGoogle Scholar
  15. Fischman MW, Smith RC, Schuster CR (1976) Effects of chlorpromazine on avoidance and escape responding in humans. Pharmacol Biochem Behav 4:111–114PubMedCrossRefGoogle Scholar
  16. Fletcher PC, Happe F, Frith U, Baker SC, Dolan RJ, Frackowiak RS, Frith CD (1995) Other minds in the brain: a functional imaging study of “theory of mind” in story comprehension. Cognition 57:109–128PubMedCrossRefGoogle Scholar
  17. Folstein MF, Folstein SE, McHugh SE (1975) “Mini-Mental State” A practical method for grading the cognitive state of patients for the clinician. J Psychiat Res 12:189–198Google Scholar
  18. Fujimura M, Hashimoto K, Yamagami K (2000) The effect of the antipsychotic drug mosapramine on the expression of Fos protein in the rat brain: comparison with haloperidol, clozapine and risperidone. Life Sci 67:2865–2872PubMedCrossRefGoogle Scholar
  19. Fukui H, Murai T, Fukuyama H, Hayashi T, Hanakawa T (2005) Functional activity related to risk anticipation during performance of the Iowa gambling task. NeuroImage 24:253–259PubMedCrossRefGoogle Scholar
  20. Gluck MA, Bower GH (1988) From conditioning to category learning: an adaptive network model. J Exp Psychol 1:25–30Google Scholar
  21. Gomar JJ, Pomarol-Clotet E, Sarro S, Salvador R, Myers CE, McKenna PJ (2011) Procedureal learning in schizophrenia: reconciling the discrepant finding. Biol Psychiatr 69:49–54CrossRefGoogle Scholar
  22. Harris MS, Wiseman CL, Reilly JL, Keshaven MS, Sweeney JA (2009) Effects of risperidone on procedural learning in antipsychotic-naive first-episode schizophrenia. Neuropsychopharmacol 34:468–476CrossRefGoogle Scholar
  23. Haw C, Stubbs J (2007) Off-label use of antipsychotics: are we mad? Expert Opin Drug Saf 6:533–545PubMedCrossRefGoogle Scholar
  24. Heindel WC, Salmon DP, Shults CW, Walicke PA, Butters N (1989) Neuropsychological evidence for multiple implicit memory systems: a comparison of Alzheimer’s, Huntington’s, and Parkinson’s disease patients. J Neurosci 9:582–587PubMedGoogle Scholar
  25. Jamrozinski K, Gruber O, Kemmer C, Falkai P, Scherk H (2009) Neurocognitive functions in euthymic bipolar patients. Acta Psychiatr Scand 119:365–374PubMedCrossRefGoogle Scholar
  26. Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261–276PubMedGoogle Scholar
  27. Knowlton BJ, Mangels JA, Squire LR (1996) A neostriatal habit learning system in humans. Science (Wash) 273:1399–1402CrossRefGoogle Scholar
  28. Koeing O, Tomas-Anterion C, Laurent B (1999) Procedural learning in Parkinson’s disease: intact and impaired cognitive components. Neuropsychologia 37:1103–1109CrossRefGoogle Scholar
  29. Kumari V, Gray JA, Corr PJ, Mulligan OF, Cotter PA, Checkley SA (1997) Effects of d-amphatamine and haloperidol on procedural learning in man. Psychopharmacology 129:271–276PubMedCrossRefGoogle Scholar
  30. Kumari V, Gray JA, Honey GD, Soni W, Bullmore E, Williams SC, Ng VW, Vythelingham GN, Simmons A, Suckling J, Corr PJ, Sharma T (2002) Procedural learning in schizophrenia: a functional magnetic resonance imaging investigation. Schizophr Res 57:97–107PubMedCrossRefGoogle Scholar
  31. Leeson VC, Robbins TW, Matheson E, Hutton S, Ron A, Barnes T, Joyce EM (2009) Discrimination learning, reversal, and set-shifting in first-episode schizophrenia: stability over six years and specific associations with medication type and disorganization syndrome. Biol Psychiatr 66:586–593CrossRefGoogle Scholar
  32. Marder S, Fenton W (2004) Measurement and treatment research to improve cognition in schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia. Schizophr Res 72:5–9PubMedCrossRefGoogle Scholar
  33. Milner B, Squire LR, Kandel ER (1998) Cognitive neuroscience and the study of memory. Neuron 20:445–468PubMedCrossRefGoogle Scholar
  34. Paquet F, Soucy JP, Stip E, Levesque M, Elie A, Bedard MA (2004) Comparison between olanzapine and haloperidol on procedural learning and the relationship with striatal D2 receptor occupancy in schizophrenia. J Neuropsych Clin N 16:47–56CrossRefGoogle Scholar
  35. Purdon SE, Woodward N, Lindborg SR (2003) Procedural learning in schizophrenia after 6 months of double-blind treatment with olanzapine, risperidone, and haloperidol. Psychopharmacology 169:390–397PubMedCrossRefGoogle Scholar
  36. Purdon SE, Waldie B, Woodward ND, Wilman AH, Tibbo P (2011) Procedural learning in first episode schizophrenia investigated with functional magnetic resonance imaging. Neuropsychology 25:147–158PubMedCrossRefGoogle Scholar
  37. Reiss JP, Campbell DW, Leslie WD, Paulus MP, Ryner LN, Polimeni JO, Foot BJ, Sareen J (2006) Deficit in schizophrenia to recruit the striatum in implicit learning: a functional magnetic resonance imaging investigation. Schizophr Res 87:127–137PubMedCrossRefGoogle Scholar
  38. Rémillard S, Pourcher E, Cohen H (2010) Long-term skill proceduralization in schizophrenia. J Int Neuropsychol Soc 16:148–156PubMedCrossRefGoogle Scholar
  39. Robertson GS, Matsumura H, Fibiger HC (1994) Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity. J Pharmacol Exp Ther 271:1058–1066PubMedGoogle Scholar
  40. Saint-Cyr JA, Taylor AE, Lang AE (1988) Procedural learning and neostriatal dysfunction in man. Brain 111:941–959PubMedCrossRefGoogle Scholar
  41. Savina I, Beninger RJ (2007) Schizophrenic patients treated with clozapine or olanzapine perform better on theory of mind tasks than those treated with risperidone or typical antipsychotic medications. Schizophr Res 94:128–138PubMedCrossRefGoogle Scholar
  42. Scherer H, Bedard M, Stip E, Paquet F, Richer F, Beriault M et al (2004) Procedural learning in schizophrenia can reflect the pharmacologic properties of the antipsychotic treatments. Cogn Behav Neurol 17:32–40PubMedCrossRefGoogle Scholar
  43. Seger CA, Cincotta CM (2005) The roles of the caudate nucleus in human classification learning. J Neurosci 25:2941–2951PubMedCrossRefGoogle Scholar
  44. Squire LR (1986) Mechanisms of memory. Science (Wash) 4758:1612–1619CrossRefGoogle Scholar
  45. Squire LR, Knowlton BJ (2000) The medial temporal lobe, the hippocampus, and the memory systems of the brain. In: Gazzaniga MS (ed) The new cognitive neurosciences. MIT Press, Cambridge, MA, pp 765–779Google Scholar
  46. Stevens A, Schwarz J, Schwarz B (2002) Implicit and explicit learning in schizophrenics treated with olanzapine and with classic neuroleptics. Psychopharmacology 160:299–306PubMedCrossRefGoogle Scholar
  47. Swainson R, Rogers RD, Sahakian BJ, Summers BA, Polkey CE, Robbins TW (2000) Probabilistic learning and reversal deficits in patients with Parkinson’s disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication. Neuropsychologia 38:596–612PubMedCrossRefGoogle Scholar
  48. Tranel D, Bechara A, Damasio AR (1999) Decision making and the somatic marker hypothesis. In: Gazzinaga MS (ed) The new cognitive neuroscience. MIT Press, Cambridge MA, pp 1115–1131Google Scholar
  49. Wan W, Ennulat DJ, Cohen BM (1995) Acute administration of typical and atypical antipsychotic drugs induces distinctive patterns of Fos expression in the rat forebrain. Brain Res 668:95–104CrossRefGoogle Scholar
  50. Weiden PJ (2007) EPS profiles: the atypical antipsychotics are not all the same. J Psychiatr Pract 13:13–24PubMedCrossRefGoogle Scholar
  51. Westerink BH (2002) Can antipsychotic drugs be classified by their effects on a particular group of dopamine neurons in the brain? Eur J Pharmacol 455:1–18PubMedCrossRefGoogle Scholar
  52. Zedkova L, Woodward ND, Harding I, Tibbo PG, Purdon SE (2006) Procedural learning in schizophrenia investigated with functional magnetic resonance imaging. Schizophr Res 88:198–207PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • James I. Wasserman
    • 1
  • Rebecca J. Barry
    • 1
  • Lisa Bradford
    • 1
  • Nicholas J. Delva
    • 2
    • 3
  • Richard J. Beninger
    • 1
    • 2
  1. 1.Department of PsychologyQueen’s UniversityKingstonCanada
  2. 2.Department of PsychiatryQueen’s UniversityKingstonCanada
  3. 3.Department of PsychiatryDalhousie UniversityHalifaxCanada

Personalised recommendations